Denis Chem Lab FY26 net profit rises 4.1% to ₹840.93 lakh
Denis Chem Lab reported a 4.1% rise in FY26 net profit to ₹840.93 lakh, with revenue growing 4.9% to ₹18,172.04 lakh. The board recommended a final dividend of ₹2.50 per share.
*this image is generated using AI for illustrative purposes only.
Denis Chem Lab reported a net profit of ₹840.93 lakh for the financial year ended March 31, 2026, marking a 4.1% increase from ₹807.58 lakh in the prior year. Revenue from operations grew 4.9% to ₹18,172.04 lakh from ₹17,329.97 lakh in FY25, supported by improved operational performance. The board has recommended a final dividend of ₹2.50 per equity share of ₹10 each for FY26, pending approval at the upcoming Annual General Meeting.
For the quarter ended March 31, 2026, the company recorded a net profit of ₹40.01 lakh, a decline from ₹70.75 lakh in the corresponding period of the previous year. Quarterly revenue from operations stood at ₹4,675.49 lakh, compared to ₹4,138.34 lakh in Q4FY25. Total expenses for the quarter increased to ₹4,615.11 lakh from ₹4,128.95 lakh, primarily due to higher material and employee costs.
The board, in its meeting on May 30, 2026, approved the standalone audited financial results. M/s. Shah & Shah Associates, Chartered Accountants, issued an unmodified opinion on the audited financial results. The company also appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors to fill a casual vacancy and M/s. Kiran J. Mehta & Co. as Cost Auditors for FY 2026-27.
Financial Performance
The company’s earnings per share (EPS) for the full year improved to ₹6.06 from ₹5.82 in the previous year. Total comprehensive income for FY26 rose to ₹855.06 lakh from ₹820.69 lakh. The finance costs for the year increased to ₹84.07 lakh from ₹51.04 lakh, while depreciation and amortization expenses remained stable at ₹683.55 lakh.
Assets and Liabilities
As of March 31, 2026, the company’s total assets stood at ₹12,482.62 lakh, up from ₹11,227.24 lakh in the previous year. Total equity increased to ₹9,157.33 lakh from ₹8,510.42 lakh. Current liabilities rose to ₹3,166.61 lakh from ₹2,617.25 lakh, largely due to an increase in trade payables and current borrowings.
| Metric | FY26 (₹ in lakh) | FY25 (₹ in lakh) | Change (%) |
|---|---|---|---|
| Revenue from operations | 18,172.04 | 17,329.97 | 4.9% |
| Net profit | 840.93 | 807.58 | 4.1% |
| Total expenses | 17,174.86 | 16,456.28 | 4.4% |
| Earnings per share (₹) | 6.06 | 5.82 | 4.1% |
Cash Flow Statement
Net cash generated from operating activities for FY26 was ₹413.15 lakh, a decrease from ₹1,209.19 lakh in the previous year. Cash used in investing activities was ₹496.50 lakh, while financing activities generated ₹44.20 lakh. Cash and cash equivalents at the end of the year stood at ₹45.88 lakh, down from ₹85.03 lakh at the end of FY25.
Historical Stock Returns for Denis Chem Lab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.61% | +4.29% | -5.11% | -13.68% | -33.00% | +26.96% |
What strategies will Denis Chem Lab implement to curb the rising material and employee costs that impacted Q4 profitability?
How will the significant decline in operating cash flow impact the company's capital expenditure plans for FY27?
Will the increase in finance costs continue to be a headwind in the coming year, and what measures are being taken to manage debt?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
